The Most Pervasive Problems With ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these medications may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders such as impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the benefits of using them against the risks to the fetus. Physicians do not have the information needed to provide clear recommendations however they can provide information about risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not have an higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a massive population-based study of case control to assess the frequency of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure correct case classification and to limit the possibility of bias.

The study of the researchers was not without limitations. The researchers were unable, in the first place to distinguish the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to establish whether the small associations observed among the groups exposed were due to medication use, or if they were confounded by co-morbidities. In addition, the researchers did not study the long-term effects of offspring on their parents.

The study revealed that infants whose mother took ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during early pregnancy could be offset by the higher benefit to both mother and child of continued treatment for the woman's disorder. Physicians should discuss this with their patients and, if possible, assist them in developing strategies for improving their coping with adhd without medication skills which can reduce the impact of her disorder on her daily life and relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are often made without clear and reliable evidence. Instead, doctors must weigh their own knowledge, the experience of other doctors, and the research on the topic.

The issue of potential risks to the infant can be particularly tricky. The research on this issue is based on observation rather than controlled studies, and the results are contradictory. The majority of studies limit their analysis to live births, which may underestimate the teratogenic impact which can cause abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these shortcomings by analyzing data on live and deceased births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies have shown an unintended, or slightly negative, effect. In each case it is imperative to conduct a thorough analysis of the benefits and risks must be performed.

It can be difficult, if not impossible for women with ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation, and family conflict for those suffering from the disorder. A decrease in medication could also affect the ability to safely drive and complete work-related tasks, which are vital aspects of everyday life for those suffering from ADHD.

She recommends that women who are unsure about whether or not to discontinue medication due to their pregnancy consider informing family members, friends and colleagues about the condition, its impact on daily functioning, and the advantages of staying on the current treatment regimen. It can also aid in ensuring that the woman feels supported when she is struggling with her decision. Certain medications can pass through the placenta. If a patient decides to not take her ADHD medication while breastfeeding, it is important to be aware that the drug could be transferred to the baby.

Risk of Birth Defects

As the use and use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential adverse effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Researchers used two massive data sets to examine more than 4.3 million pregnancy and determine whether stimulant medications increased birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects like ventriculoseptal defect.

The researchers of the study found no association between the use of early medications and other congenital abnormalities, like facial clefting, or club foot. The results are consistent with previous studies revealing the presence of a small, but significant increase in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk grew in the latter half of pregnancy, when a lot of women decide to stop taking their ADHD medication.

Women who used ADHD medications during the first trimester of their pregnancy were also more likely to experience caesarean section, low Apgar score after delivery and a baby that required breathing assistance during birth. However the authors of the study were not able to eliminate selection bias by restricting the study to women who did not have any other medical issues that could have contributed to these findings.

Researchers hope that their study will inform physicians when they see pregnant women. The researchers advise that while discussing the risks and benefits are crucial, the decision about whether to continue or stop medication should be according to the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also advise that, while stopping the medication is an option, it isn't an option that is recommended due to the high incidence of depression and other mental health problems for women who are expecting or postpartum. Further, the research suggests that women who choose to stop taking their medications are more likely to have difficulties adapting to life without them after the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women suffering from ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to a new adhd medication routine. Many women opt to continue taking their Inattentive Adhd Medication Adults medication during pregnancy.

The majority of stimulant medicines are absorbed through breast milk in small amounts, so the risk for infant who is breastfeeding is low. However, the amount of medication exposure to the newborn can vary depending on the dosage, frequency it is taken and the time of day it is administered. In addition, different drugs enter the infant's system through the gastrointestinal tract or breast milk. The impact on the health of a newborn isn't fully known.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication against the possible dangers to the foetus. Until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal period.

A increasing number of studies have shown that most women can safely continue their ADHD medication while they are pregnant and nursing. In response, a growing number of patients are choosing to continue their medication. They have found after consulting with their doctor, that the benefits of continuing their current medication far outweigh any risk.

It is crucial for women suffering from ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons for continuing treatment. This includes non stimulant adhd medication list-pharmacological methods. Psychoeducation should also be offered to help pregnant people with ADHD be aware of their symptoms and underlying disorder, learn about available treatment options and strengthen existing strategies for managing. This should be a multidisciplinary effort together with obstetricians, GPs, and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and child, and monitoring for indicators of deterioration, and, if needed, adjustments to the medication regime.